HIT Consultant May 8, 2020
What You Should Know:
– As the government guides state re-openings, digital health startup BioIntelliSense announced the newest advancements of its medical-grade biosensor solution portfolio and Data-as-a-Service (DaaS) platform.
– The company’s new COVID-19 Return to Work and School solution generates a more reliable clinical assessment of an individual’s infectious risk status through home-based screening tools and data-driven clearance scores.
– The new BioButton™ is a single-use, coin-sized, disposable wearable medical device that continuously monitors COVID-related vital signs: temperature, respiratory rate at rest, and activity level for scalable enterprise workforce and student health deployments for 90 days.
BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced the advancement of its medical-grade biosensor product portfolio and Data-as-a-Service...
Today's Sponsors
Today's Sponsor